Conversely, OS of stage III CRC was not influenced by the RIPMSI mutation in patients with familial CRC, wild-type BRAF tumors or younger than 55 years (Supplementary Figure S9D–F). The gene discussed is BRAF; the disease is colorectal carcinoma.